Lista de obras -

11C-sorafenib and 15O-H2O PET for early evaluation of sorafenib therapy

artículo científico publicado en 2020

A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems

artículo científico publicado en 2015

A multi species evaluation of the radiation dosimetry of [11C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor

artículo científico publicado en 2017

Altered GABAA receptor density and unaltered blood-brain barrier [11C]flumazenil transport in drug-resistant epilepsy patients with mesial temporal sclerosis

artículo científico publicado en 2015

Amyloid and its association with default network integrity in Alzheimer's disease

artículo científico publicado en 2012

Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology

artículo científico publicado en 2012

Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studies

artículo científico publicado en 2007

Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findings

artículo científico publicado en 2010

Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET.

artículo científico publicado en 2009

Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC.

artículo científico publicado en 2016

Effects of image characteristics on performance of tumor delineation methods: a test-retest assessment

artículo científico publicado en 2011

Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies

artículo científico publicado en 2011

Evaluation of tracer kinetic models for analysis of [18F]FDDNP studies

artículo científico publicado en 2009

Feasibility of state of the art PET/CT systems performance harmonisation.

artículo científico publicado en 2018

Impact of PET/CT system, reconstruction protocol, data analysis method, and repositioning on PET/CT precision: An experimental evaluation using an oncology and brain phantom.

artículo científico publicado en 2017

Impact of [¹⁸F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology

artículo científico publicado en 2011

In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis

artículo científico publicado en 2016

Investigating the state-of-the-art in whole-body MR-based attenuation correction: an intra-individual, inter-system, inventory study on three clinical PET/MR systems

artículo científico publicado en 2016

Investigation of practical initial attenuation image estimates in TOF-MLAA reconstruction for PET/MR.

artículo científico publicado en 2016

Longitudinal amyloid imaging using 11C-PiB: methodologic considerations

artículo científico publicado en 2013

Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.

artículo científico publicado en 2012

Measurement of metabolic tumor volume: static versus dynamic FDG scans

artículo científico publicado en 2011

Methodological considerations in quantification of 3'-deoxy-3'-[18F]fluorothymidine uptake measured with positron emission tomography in patients with non-small cell lung cancer

artículo científico publicado en 2014

Model selection criteria for dynamic brain PET studies

artículo científico publicado en 2017

Molecular Imaging of ABCB1/ABCG2 Inhibition at the Human Blood Brain Barrier using Elacridar and 11C-Erlotinib PET.

artículo científico publicado en 2017

Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images

artículo científico publicado en 2010

Multi-tracer model for staging cortical amyloid deposition using PET imaging

artículo científico publicado en 2020

Optimization algorithms and weighting factors for analysis of dynamic PET studies.

artículo científico publicado en 2006

Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies

artículo científico publicado en 2012

Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies

artículo científico publicado en 2019

Parametric Methods for Dynamic 11C-Phenytoin PET Studies

artículo científico publicado en 2016

Parametric methods for quantification of 18F-FAZA kinetics in non-small cell lung cancer patients

artículo científico

Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients.

artículo científico publicado en 2013

Quality control for quantitative multicenter whole-body PET/MR studies: A NEMA image quality phantom study with three current PET/MR systems

artículo científico publicado en 2015

Quantification of Dynamic 11C-Phenytoin PET Studies

artículo científico publicado en 2015

Quantification of Tau Load Using [(18)F]AV1451 PET.

artículo científico publicado en 2017

Quantification of dopamine transporter binding using [18F]FP-beta-CIT and positron emission tomography

artículo científico publicado en 2006

Quantitative Assessment of Arthritis Activity in Rheumatoid Arthritis Patients Using [11C]DPA-713 Positron Emission Tomography

artículo científico publicado en 2020

Quantitative and Simplified Analysis of 11C-Erlotinib Studies

artículo científico publicado en 2016

Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding

artículo científico publicado en 2009

Reproducibility and repeatability of semi-quantitative 18F-fluorodihydrotestosterone (FDHT) uptake metrics in castration-resistant prostate cancer metastases: a prospective multi-center study.

artículo científico publicado en 2018

Semi-quantitative cerebral blood flow parameters derived from non-invasive [(15)O]H2O PET studies.

artículo científico publicado en 2017

Simplified parametric methods for [11C]PIB studies

artículo científico publicado en 2008

Simplified parametric methods for [18F]FDDNP studies.

artículo científico publicado en 2009

Test-retest variability of quantitative [11C]PIB studies in Alzheimer's disease

artículo científico publicado en 2009

The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects

artículo científico publicado en 2014

The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease

artículo científico publicado en 2014

Widespread and prolonged increase in (R)-(11)C-PK11195 binding after traumatic brain injury

artículo científico publicado en 2011

[11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors

artículo científico publicado en 2013

[11C]PIB amyloid quantification: effect of reference region selection

artículo científico publicado en 2020

Lista de obras de

11C-sorafenib and 15O-H2O PET for early evaluation of sorafenib therapy

A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems

A multi species evaluation of the radiation dosimetry of [11C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor

Altered GABAA receptor density and unaltered blood-brain barrier [11C]flumazenil transport in drug-resistant epilepsy patients with mesial temporal sclerosis

Amyloid and its association with default network integrity in Alzheimer's disease

Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology

Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studies

Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findings

Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET.

Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC.

Effects of image characteristics on performance of tumor delineation methods: a test-retest assessment

Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies

Evaluation of tracer kinetic models for analysis of [18F]FDDNP studies

Feasibility of state of the art PET/CT systems performance harmonisation.

Impact of PET/CT system, reconstruction protocol, data analysis method, and repositioning on PET/CT precision: An experimental evaluation using an oncology and brain phantom.

Impact of [¹⁸F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology

In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis

Investigating the state-of-the-art in whole-body MR-based attenuation correction: an intra-individual, inter-system, inventory study on three clinical PET/MR systems

Investigation of practical initial attenuation image estimates in TOF-MLAA reconstruction for PET/MR.

Longitudinal amyloid imaging using 11C-PiB: methodologic considerations

Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.

Measurement of metabolic tumor volume: static versus dynamic FDG scans

Methodological considerations in quantification of 3'-deoxy-3'-[18F]fluorothymidine uptake measured with positron emission tomography in patients with non-small cell lung cancer

Model selection criteria for dynamic brain PET studies

Molecular Imaging of ABCB1/ABCG2 Inhibition at the Human Blood Brain Barrier using Elacridar and 11C-Erlotinib PET.

Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images

Multi-tracer model for staging cortical amyloid deposition using PET imaging

Optimization algorithms and weighting factors for analysis of dynamic PET studies.

Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies

Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies

Parametric Methods for Dynamic 11C-Phenytoin PET Studies

Parametric methods for quantification of 18F-FAZA kinetics in non-small cell lung cancer patients

Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients.

Quality control for quantitative multicenter whole-body PET/MR studies: A NEMA image quality phantom study with three current PET/MR systems

Quantification of Dynamic 11C-Phenytoin PET Studies

Quantification of Tau Load Using [(18)F]AV1451 PET.

Quantification of dopamine transporter binding using [18F]FP-beta-CIT and positron emission tomography

Quantitative Assessment of Arthritis Activity in Rheumatoid Arthritis Patients Using [11C]DPA-713 Positron Emission Tomography

Quantitative and Simplified Analysis of 11C-Erlotinib Studies

Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding

Reproducibility and repeatability of semi-quantitative 18F-fluorodihydrotestosterone (FDHT) uptake metrics in castration-resistant prostate cancer metastases: a prospective multi-center study.

Semi-quantitative cerebral blood flow parameters derived from non-invasive [(15)O]H2O PET studies.

Simplified parametric methods for [11C]PIB studies

Simplified parametric methods for [18F]FDDNP studies.

Test-retest variability of quantitative [11C]PIB studies in Alzheimer's disease

The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects

The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease

Widespread and prolonged increase in (R)-(11)C-PK11195 binding after traumatic brain injury

[11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors

[11C]PIB amyloid quantification: effect of reference region selection